Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Other Working Capital Changes (2016 - 2025)

Historic Other Working Capital Changes for Amphastar Pharmaceuticals (AMPH) over the last 13 years, with Q3 2025 value amounting to $7422.0.

  • Amphastar Pharmaceuticals' Other Working Capital Changes fell 9993.08% to $7422.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $7422.0, marking a year-over-year decrease of 9994.43%. This contributed to the annual value of $10.7 million for FY2024, which is 197522228.36% up from last year.
  • Per Amphastar Pharmaceuticals' latest filing, its Other Working Capital Changes stood at $7422.0 for Q3 2025, which was down 9993.08% from $66.0 recorded in Q2 2025.
  • Over the past 5 years, Amphastar Pharmaceuticals' Other Working Capital Changes peaked at $10.7 million during Q3 2024, and registered a low of -$1.8 million during Q4 2021.
  • Over the past 5 years, Amphastar Pharmaceuticals' median Other Working Capital Changes value was $5614.0 (recorded in 2022), while the average stood at $695583.0.
  • Examining YoY changes over the last 5 years, Amphastar Pharmaceuticals' Other Working Capital Changes showed a top increase of 197595893.19% in 2024 and a maximum decrease of 8670000.0% in 2024.
  • Amphastar Pharmaceuticals' Other Working Capital Changes (Quarter) stood at -$1.8 million in 2021, then soared by 282.32% to $3.2 million in 2022, then decreased by 11.36% to $2.8 million in 2023, then tumbled by 91.63% to $237000.0 in 2024, then plummeted by 96.87% to $7422.0 in 2025.
  • Its last three reported values are $7422.0 in Q3 2025, $66.0 for Q2 2025, and $849000.0 during Q1 2025.